S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Biden's latest bailout--terrible for America? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Biden's latest bailout--terrible for America? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Biden's latest bailout--terrible for America? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Biden's latest bailout--terrible for America? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Biden's latest bailout--terrible for America? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Biden's latest bailout--terrible for America? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Biden's latest bailout--terrible for America? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Biden's latest bailout--terrible for America? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?

Apyx Medical (APYX) Stock Forecast, Price & News

$3.22
-0.10 (-3.01%)
(As of 09/22/2023 ET)
Compare
Today's Range
$3.20
$3.45
50-Day Range
$3.22
$6.20
52-Week Range
$1.31
$7.97
Volume
154,261 shs
Average Volume
74,877 shs
Market Capitalization
$111.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.88

Apyx Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
144.6% Upside
$7.88 Price Target
Short Interest
Bearish
9.44% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.07
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$113,400 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.38) to ($0.49) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.21 out of 5 stars

Medical Sector

372nd out of 962 stocks

Surgical & Medical Instruments Industry

47th out of 97 stocks


APYX stock logo

About Apyx Medical (NASDAQ:APYX) Stock

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

APYX Price History

APYX Stock News Headlines

Short Interest in Apyx Medical Co. (NASDAQ:APYX) Drops By 16.7%
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Q2 2023 Apyx Medical Corp Earnings Call
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
BOV.SG - Apyx Medical Corp
APYX - Apyx Medical Corporation
Lake Street Keeps Their Buy Rating on NeuroPace (NPCE)
Apyx Hails FDA Breakthrough, Shares Flat
Craig-Hallum Keeps Their Buy Rating on Apyx Medical (APYX)
See More Headlines
Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Company Calendar

Last Earnings
8/10/2023
Today
9/24/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APYX
Employees
276
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.88
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$4.50
Forecasted Upside/Downside
+144.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-23,180,000.00
Pretax Margin
-38.81%

Debt

Sales & Book Value

Annual Sales
$44.51 million
Book Value
$1.09 per share

Miscellaneous

Free Float
30,106,000
Market Cap
$111.54 million
Optionable
Optionable
Beta
1.20
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Charles D. Goodwin II (Age 57)
    Pres, CEO & Director
    Comp: $505.44k
  • Ms. Tara H. Semb (Age 53)
    CFO, Treasurer & Sec.
    Comp: $360.05k
  • Mr. Moshe Citronowicz (Age 70)
    Sr. VP
    Comp: $332.94k
  • Mr. Todd Hornsby (Age 47)
    Exec. VP
    Comp: $394.78k













APYX Stock - Frequently Asked Questions

Should I buy or sell Apyx Medical stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" APYX shares.
View APYX analyst ratings
or view top-rated stocks.

What is Apyx Medical's stock price forecast for 2023?

4 brokers have issued 1-year price objectives for Apyx Medical's shares. Their APYX share price forecasts range from $4.50 to $10.00. On average, they predict the company's share price to reach $7.88 in the next twelve months. This suggests a possible upside of 144.6% from the stock's current price.
View analysts price targets for APYX
or view top-rated stocks among Wall Street analysts.

How have APYX shares performed in 2023?

Apyx Medical's stock was trading at $2.34 at the beginning of the year. Since then, APYX stock has increased by 37.6% and is now trading at $3.22.
View the best growth stocks for 2023 here
.

Are investors shorting Apyx Medical?

Apyx Medical saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 2,850,000 shares, a drop of 16.7% from the August 15th total of 3,420,000 shares. Based on an average daily volume of 269,300 shares, the days-to-cover ratio is currently 10.6 days. Approximately 9.4% of the shares of the stock are sold short.
View Apyx Medical's Short Interest
.

When is Apyx Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our APYX earnings forecast
.

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) issued its quarterly earnings results on Thursday, August, 10th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.01. The business had revenue of $13.57 million for the quarter, compared to the consensus estimate of $14.25 million. Apyx Medical had a negative trailing twelve-month return on equity of 49.64% and a negative net margin of 34.34%.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical updated its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $59.00 million-$62.00 million, compared to the consensus revenue estimate of $59.99 million.

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Divisadero Street Capital Management LP (6.60%), Royce & Associates LP (4.63%), Pura Vida Investments LLC (2.86%), Cowen Prime Advisors LLC (1.75%), Taylor Frigon Capital Management LLC (1.55%) and BlackRock Inc. (1.55%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby.
View institutional ownership trends
.

How do I buy shares of Apyx Medical?

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $3.22.

How much money does Apyx Medical make?

Apyx Medical (NASDAQ:APYX) has a market capitalization of $111.54 million and generates $44.51 million in revenue each year. The company earns $-23,180,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis.

How many employees does Apyx Medical have?

The company employs 276 workers across the globe.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The official website for the company is www.apyxmedical.com. The company can be reached via phone at (727) 384-2323, via email at investor.relations@apyxmedical.com, or via fax at 800-323-1640.

This page (NASDAQ:APYX) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -